Blar i NTNU Open på forfatter "Myklebust, Tor Åge"

Viser treff 41-43 av 43

    • T1 bladder cancer in Norway: treatment and survival 

      Blindheim, Augun Jodis; Fosså, Sophie Dorothea; Babigumira, Ronnie; Myklebust, Tor Åge; Haug, Erik Skaaheim; Arum, Carl-Jørgen; Kulle, Bettina (Peer reviewed; Journal article, 2020)
      Aim: Evaluation of treatment and survival of pT1 stage (T1) bladder cancer (BC) patients diagnosed with transitional cell carcinoma of the urinary bladder in Norway. Material and methods: According to the Cancer Registry ...

    • Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort 

      Hellesnes, Ragnhild; Myklebust, Tor Åge; Fosså, Sophie Dorothea; Bremnes, Roy M.; Karlsdottir, Åsa; Kvammen, Øivind; Tandstad, Torgrim; Wilsgaard, Tom; Negaard, Helene Francisca Stigter; Haugnes, Hege Sagstuen (Peer reviewed; Journal article, 2021)
      PURPOSE Using complete information regarding testicular cancer (TC) treatment burden, this study aimed to investigate cause-specific non-TC mortality with impact on previous treatment with platinum-based chemotherapy (PBCT) ...

    • Treatment and 30-day mortality after myocardial infarction in prostate cancer patients: A population-based study from Norway 

      Forster, Rachel Bedenis; Kjellstadli, Camilla; Myklebust, Tor Åge; Egeland, Grace M.; Sulo, Gerhard; Bjørge, Tone; Bønaa, Kaare Harald; Juliusson, Pétur Benedikt; Kvåle, Rune (Peer reviewed; Journal article, 2022)
      Introduction: There is limited knowledge about the use of invasive treatment and mortality after acute myocardial infarction (AMI) in prostate cancer (PCa) patients. We therefore wanted to compare rates of invasive treatment ...